Ligand Pharmaceuticals Inc SEC filings LGNXZ
Ligand Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to May 14, 2015. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| CT ORDER | Filing | Apr 26, 2023 | — |
| 425 | Filing | Oct 3, 2022 | — |
| 425 | Filing | Aug 24, 2022 | — |
| 425 | Filing | Jun 21, 2022 | — |
| 425 | Filing | May 5, 2022 | — |
| 425 | Filing | Mar 24, 2022 | — |
| 425 | Filing | Mar 23, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2021 | — |
| CORRESP | Letter to the SEC | Jan 6, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2020 | — |
| SC TO-T/A | Filing | Sep 30, 2020 | — |
| CORRESP | Letter to the SEC | Sep 16, 2020 | — |
| SC TO-T/A | Filing | Sep 16, 2020 | — |
| SC TO-T/A | Filing | Sep 11, 2020 | — |
| SC TO-T | Filing | Aug 31, 2020 | — |
| SC TO-C | Filing | Aug 11, 2020 | — |
| SC TO-C | Filing | Aug 11, 2020 | — |
| CT ORDER | Filing | Jun 15, 2020 | — |
| CT ORDER | Filing | Aug 24, 2018 | — |
| PRER14A | Filing | May 23, 2018 | — |
| CT ORDER | Filing | May 22, 2018 | — |
| CT ORDER | Filing | Apr 3, 2018 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2018 | — |
| CORRESP | Letter to the SEC | Jan 17, 2018 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2017 | — |
| CT ORDER | Filing | Nov 13, 2017 | — |
| CT ORDER | Filing | Jun 27, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 14, 2017 | — |
| CORRESP | Letter to the SEC | Feb 9, 2017 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2017 | — |
| CORRESP | Letter to the SEC | Jan 3, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2016 | — |
| NT 10-Q | Filing | Nov 9, 2016 | Sep 30, 2016 |
| CT ORDER | Filing | Sep 16, 2016 | — |
| CT ORDER | Filing | Jul 26, 2016 | — |
| CT ORDER | Filing | Jul 19, 2016 | — |
| CT ORDER | Filing | Jun 9, 2016 | — |
| CT ORDER | Filing | Jun 7, 2016 | — |
| CT ORDER | Filing | Jun 7, 2016 | — |
| CT ORDER | Filing | Apr 18, 2016 | — |
| CT ORDER | Filing | Apr 12, 2016 | — |
| D | Filing | Jan 25, 2016 | — |
| CT ORDER | Filing | Jan 15, 2016 | — |
| CT ORDER | Filing | Aug 28, 2015 | — |
Showing 44 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LGND (Nasdaq), LGNDZ (OTC), LGNXZ (OTC), LGNYZ (OTC), LGNZZ (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 886163
- Former names
- LIGAND PHARMACEUTICALS (until Sep 13, 1994)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.